Authors

• Xiang Cheng (ORCID: https://orcid.org/0000-0002-6287-3128)
• Zhuang Tian
• Qing Zhang (ORCID: https://orcid.org/0000-0002-5652-4036)
• Yu-Mao Chen
• Yunqi Shi
• Daoquan Peng
• Wei Ma (ORCID: https://orcid.org/0000-0003-1305-3980)
• Liwen Li (ORCID: https://orcid.org/0000-0001-9120-5260)
• Yuanqiang Zhang (ORCID: https://orcid.org/0000-0002-4592-4966)
• Jianan Wang (ORCID: https://orcid.org/0000-0003-0409-8941)
• Xiaoyan Li (ORCID: https://orcid.org/0000-0002-7454-7821)
• Jing Zheng
• Wei Jin (ORCID: https://orcid.org/0000-0002-2905-2109)
• Yue Zhong (ORCID: https://orcid.org/0000-0003-4978-6510)
• Yu Chen Barrett
• Ping Yang
• Fang Wang (ORCID: https://orcid.org/0000-0002-8808-8531)

Institutions

• Union Hospital (HK)
• Central South University (CN)
• Jilin University (CN)
• Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
• Peking University (CN)
• Sichuan University (CN)
• Peking Union Medical College Hospital (CN)
• Ruijin Hospital (CN)
• Wuhan University (CN)
• West China Hospital of Sichuan University (CN)
• Bristol-Myers Squibb (United States) (US)
• Liaoning Provincial People's Hospital (CN)
• Beijing Hospital (CN)
• Wuhan Union Hospital (CN)
• Peking University First Hospital (CN)
• Renmin Hospital of Wuhan University (CN)
• Second Xiangya Hospital of Central South University (CN)
• Guangdong Provincial People's Hospital (CN)
• Second Affiliated Hospital of Zhejiang University (CN)

Publication Details

Journal

Cardiology and Therapy

Published

2025-04-29

DOI

https://doi.org/10.1007/s40119-025-00409-5

Citations

4

Primary Topic

Cardiomyopathy and Myosin Studies

Type

article

Field-Weighted Citation Impact

5.55

Funders

• Bristol-Myers Squibb